The fda wanted additional data. They now have that additional.
Nothing stopping the FDA from saying Remestemcel-L APPROVED
treatment for sr-aGVHD.
The fda wanted additional data. They now have that additional....
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
-0.050(4.24%) |
Mkt cap ! $1.293B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.18 | $1.13 | $3.838M | 3.361M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 101355 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 43001 | 12 |
View Market Depth
| Last trade - 14.16pm 17/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |